Abiopharma

🔍 Ribeiro Sergio Passos (Executive)

Company: Vinci Compass Investments Ltd. (VINP)

Report Date: 2026-03-26

Detailed Transactions and Holdings:

• Sold 1,152 shares of Class A Common Shares at $10.23 per share (Direct)
  Date: 2026-03-26 | Code: S | equity_swap_involved: 0 | shares_owned_after: 340,041.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 1,698 shares of Class A Common Shares at $10.02 per share (Direct)
  Date: 2026-03-27 | Code: S | equity_swap_involved: 0 | shares_owned_after: 338,343.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 2,252 shares of Class A Common Shares at $10.07 per share (Direct)
  Date: 2026-03-30 | Code: S | equity_swap_involved: 0 | shares_owned_after: 336,091.00 | transaction_form_type: 4 | Footnotes: F1, F4
• Sold 1,832 shares of Class A Common Shares at $10.43 per share (Direct)
  Date: 2026-03-31 | Code: S | equity_swap_involved: 0 | shares_owned_after: 334,259.00 | transaction_form_type: 4 | Footnotes: F1, F5
• Holds 0 shares of Class A Common Shares (Direct)
  Date: 2026-03-26 | Code: H | nature_of_ownership: By: SPR Opportunity Investments | shares_owned_after: 465,967.00

Footnotes:

• F1: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2025.
• F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.69 to $10.34, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
• F3: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.73 to $10.20, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.
• F4: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.94 to $10.40, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (4) to this Form 4.
• F5: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.16 to $10.59, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (5) to this Form 4.